Trade RCEL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Avita Medical, Inc. (RCEL) is trading at US$12.94, down 0.86% today as of Oct 8, 12:28 EDT. The company has a market capitalisation of US$311.12M. Over the past 52 weeks, RCEL has traded between US$3.22 and US$13.50. On Syfe you can trade RCEL with $0 commission and add it to your watchlist.
| Previous close | US$13.05 |
|---|---|
| Market cap | US$311.12M |
| 52-week range | US$3.22 – US$13.50 |
| Volume | 262.31K |
| Exchange | US |
Avita Medical, Inc.
AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. Its product, RECELL system, is a device that enables healthcare professionals to produce a suspension of spray-on skin cells using a small sample of the patient's own skin for the treatment of acute thermal burns. The company was founded in December 1992 and is headquartered in Valencia, CA.
Year: 2012
Avita Medical Says PermeaDerm Study Meets Primary Endpoint, Showing 70% Cost Reduction
Aug 18, 12:15 PM · MT Newswires
--BTIG Upgrades AVITA Medical to Buy From Neutral, $7 Price Target
Aug 7, 12:01 PM · MT Newswires
AVITA Medical Q1 Loss Narrows, Revenue Rises; 2026 Revenue Guidance Reaffirmed
May 14, 8:36 PM · MT Newswires
AVITA Medical Names Cary Vance as CEO
Apr 30, 2:48 PM · MT Newswires
Avita Medical, Inc. (RCEL) stock is trading at US$12.94, -0.86% from the previous close of US$13.05.
The market cap for Avita Medical, Inc. (RCEL) stock is approximately US$311.12M.
The 52-week high for Avita Medical, Inc. (RCEL) stock is US$13.50.
The 52-week low for Avita Medical, Inc. (RCEL) stock is US$3.22.
Avita Medical, Inc. (RCEL) does not currently pay a dividend.
Stay on top of RCEL
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
